Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Siddhartha Yadav

Showing results (61-70 of 122) with videos related to

Pageof 13
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020
A Novel Clinically Based Staging System for Gallbladder CancerSiddhartha Yadav, Sri Harsha Tella, Anuhya Kommalapati, et al.
Human Mutation|May 23, 2020
Mutation prevalence tables for hereditary cancer derived from multigene panel testingSteven N Hart, Eric C Polley, Amal Yussuf, et al.
Journal of the National Cancer Institute|February 25, 2020
The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing CohortChunling Hu, Eric C Polley, Siddhartha Yadav, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 28, 2019
Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysisSiddhartha Yadav, Hao Xie, Irbaz Bin-Riaz, et al.
Ebiomedicine|April 9, 2020
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancerManish Kohli, Winston Tan, Tiantian Zheng, et al.
Gynecologic Oncology|June 2, 2026
Clinical relevance of transcriptome profiling for assessing prognosis, platinum insensitivity, and precision therapeutics in endometrial cancerJesus Gonzalez-Bosquet, Maryam Shahi, Siddhartha Yadav, et al.
Plos One|December 1, 2022
ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancerJesus Gonzalez-Bosquet, S John Weroha, Jamie N Bakkum-Gamez, et al.
The Oncologist|November 11, 2018
Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical TrialsNarjust Duma, Sejal M Kothadia, Tariq U Azam, et al.
BJC Reports|June 3, 2026
Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studiesIsaac Allen, Nancy Whish, Siddhartha Yadav, et al.
Frontiers in Oncology|June 8, 2023
Prognostic stratification of endometrial cancers with high microsatellite instability or no specific molecular profileJesus Gonzalez-Bosquet, S John Weroha, Jamie N Bakkum-Gamez, et al.
Pageof 13

Showing results (61-70 of 122) with videos related to

Sort By:
Pageof 13
Journal of the National Comprehensive Cancer Network : JNCCN|February 6, 2020
A Novel Clinically Based Staging System for Gallbladder CancerSiddhartha Yadav, Sri Harsha Tella, Anuhya Kommalapati, et al.
Human Mutation|May 23, 2020
Mutation prevalence tables for hereditary cancer derived from multigene panel testingSteven N Hart, Eric C Polley, Amal Yussuf, et al.
Journal of the National Cancer Institute|February 25, 2020
The Contribution of Germline Predisposition Gene Mutations to Clinical Subtypes of Invasive Breast Cancer From a Clinical Genetic Testing CohortChunling Hu, Eric C Polley, Siddhartha Yadav, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 28, 2019
Neoadjuvant vs. adjuvant chemotherapy for cholangiocarcinoma: A propensity score matched analysisSiddhartha Yadav, Hao Xie, Irbaz Bin-Riaz, et al.
Ebiomedicine|April 9, 2020
Clinical and genomic insights into circulating tumor DNA-based alterations across the spectrum of metastatic hormone-sensitive and castrate-resistant prostate cancerManish Kohli, Winston Tan, Tiantian Zheng, et al.
Gynecologic Oncology|June 2, 2026
Clinical relevance of transcriptome profiling for assessing prognosis, platinum insensitivity, and precision therapeutics in endometrial cancerJesus Gonzalez-Bosquet, Maryam Shahi, Siddhartha Yadav, et al.
Plos One|December 1, 2022
ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancerJesus Gonzalez-Bosquet, S John Weroha, Jamie N Bakkum-Gamez, et al.
The Oncologist|November 11, 2018
Characterization of Comorbidities Limiting the Recruitment of Patients in Early Phase Clinical TrialsNarjust Duma, Sejal M Kothadia, Tariq U Azam, et al.
BJC Reports|June 3, 2026
Contralateral breast cancer risks for BRCA1, BRCA2, PALB2, CHEK2, and ATM pathogenic variant carriers in two large cohort studiesIsaac Allen, Nancy Whish, Siddhartha Yadav, et al.
Frontiers in Oncology|June 8, 2023
Prognostic stratification of endometrial cancers with high microsatellite instability or no specific molecular profileJesus Gonzalez-Bosquet, S John Weroha, Jamie N Bakkum-Gamez, et al.
Pageof 13